StockData
BioHarvest Sciences Inc. logo

BioHarvest Sciences Inc. (BHST) stock

BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.50−0.13 (-7.67%)

Close on Nov 13, 2026Market cap $34.11MP/E –Yield –

BioHarvest Sciences gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 59.3%, against 55.4% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202559.3%+4.0
FY2024Dec 31, 202455.4%+10.9
FY2023Dec 31, 202344.5%–

More BioHarvest Sciences figures

See a number that looks wrong?